This information was published on 2026-04-01T00:07:40 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2611273 (IR 1890496) |
| (220) |
03 Nov 2025
|
| (300) |
US, 31 Oct 2025, 99474175
|
| (511) (510) |
Class 5
Pharmaceutical preparations for diagnosing and treating neurodegenerative diseases; pharmaceutical preparations for the treatment and prevention of lysosomal storage diseases. |
| (540) | AVLAYAH |
| (550) | Word |
| (730) |
Denali Therapeutics Inc.
|
Find out more about publications on the About page.